INS and breast cancer: Considering that insulin and IGFs are able to bind to and activate each other’s receptors and share common downstream signaling pathways [78, 79], BCAHC‐1 cells may represent a valuable model system for a comprehensive evaluation of insulin/IR signaling in BC.